Human lipopolysaccharides antibody IgG (LPS-IgG) ELISA Kit (Quantitative)

SL3130Hu_1 96 Tests
EUR 468

Human IgG antibody Laboratories manufactures the elisa quantitative for protein concentration reagents distributed by Genprice. The Elisa Quantitative For Protein Concentration reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact protein elisa. Other Elisa products are available in stock. Specificity: Elisa Category: Quantitative Group: For Protein

Linsmaier and Skoog Vitamin Concentration (Syringe Vials)

100 mL
EUR 43.46

Schenk and Hildebrandt Vitamin Concentration (Syringe Vials)

100 mL
EUR 43.56

Human Anti-Aflibercept/Eylea IgG (anti-drug IgG) ELISA Kit for human, 96 tests, quantitative

1 Kit
EUR 1365.6

Human Anti-Avastin/Bevacizumab IgG (anti-drug IgG) ELISA Kit for human, 96 tests, quantitative

1 kit
EUR 1365.6

Human Anti-Lucentis/Ranibizumab IgG (anti-drug IgG) ELISA Kit for human, 96 tests, quantitative

1 Kit
EUR 1365.6

88 Allergen IgG Screening ELISA Kit for Human (1 patient), Quantitative

1 Kit
EUR 927.6

True Blue

5.0mg
EUR 595

For Protein information

Cas9 Null Mutant GFP NLS Protein (High Concentration)

K186 47µg (250pmol) Volume: 25µL
EUR 155
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;The Cas9 Null Mutant Protein is created by mutating both cleavage domains of the wild type Cas9 (D10A and H840A). Such a Cas9 protein retains its ability to bind to genomic DNA through gRNA:genomic DNA base pairing, however, unlike Cas9 Nuclease and Cas9 Nickase, where permanent gene disruption can be achieved, the Cas9 Null Mutant does not introduce any genome modifications. Therefore, this protein can provide a useful negative control for CRISPR experiments. In addition, binding of the Null Mutant can act as a roadblock to hinder transcription, thus offering a useful tool to achieve reversible knock-down of gene expression. ;The Cas9 from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. ;The fusion of Cas9 to GFP allows for visual confirmation of transfection as well as subsequent verification of Cas9 clearance from the cells. Cas9 Null Mutant GFP can also be used for FACS applications and screening. Cas9 D10A Null Mutant GFP NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.

Cas9 D10A Nickase GFP NLS Protein (High Concentration)

K149 47µg (250pmol) Volume: 25µL
EUR 155
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. One concern with the current CRISPR Cas9 technology is the potential off-target effects of the Cas9 nuclease. ;To counteract off-target mutagenic effects of this system, the Cas9 Nickase D10A was developed with a D10A mutation in its RuvC1 nuclease domain. Unlike the Cas9 nuclease, this mutant form generates a single stranded nick instead of a double-strand break (DSB). Because a single DNA nick is quickly repaired with high fidelity by the cellular machinery, the system requires two closely juxtaposed nicks in order to trigger the same genomic disruption as the Cas9 nuclease. This effectively boosts the recognition sequence to 40 instead of 20 nucleotides, and, as a result, off-target effects become highly unlikely. Thus, the double-nickase CRISPR system offers unparalleled specificity to satisfy even the most stringent of experimental requirements. ;The Cas9 from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. ;The fusion of Cas9 to GFP allows for visual confirmation of transfection as well as subsequent verification of Cas9 clearance from the cells. Cas9 D10A Nickase-GFP can also be used for FACS applications and screening. Cas9 D10A Nickase -GFP NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein.

ddATP - high concentration

NU-271L 5 x 10µl
EUR 146.8

ddATP - high concentration

NU-271S 10µl
EUR 51.9

ddCTP - high concentration

NU-272L 5 x 10µl
EUR 146.8

ddCTP - high concentration

NU-272S 10µl
EUR 51.9

ddGTP - high concentration

NU-273L 5 x 10µl
EUR 146.8

ddGTP - high concentration

NU-273S 10µl
EUR 51.9

ddTTP - high concentration

NU-274L 5 x 10µl
EUR 146.8

ddTTP - high concentration

NU-274S 10µl
EUR 51.9

ETHANOL, 70% CONCENTRATION

IB15727 10L
EUR 210.13
Description: BOX W/SPIGOT (HAZ)

pSET152- Low concentration

PVT11339 2 ug
EUR 444

Non-Interfering Protein Concentration Determination Kit

SK3071 250Assays, 250preps
EUR 130.99

pSET152- high concentration

PVT11338 2 ug
EUR 444

Cumate Solution, high concentration, 10,000x for use with PiggyBac

PBQM100A-1 500 ul
EUR 106

BD High Concentration Laminin

354259 EACH
EUR 754.8

Lentivirus concentration reagent

E28F06205 100ml
EUR 336.51